# Signaling and Biotechology Program

> **NIH NIH P30** · WAKE FOREST UNIVERSITY HEALTH SCIENCES · 2020 · $34,569

## Abstract

The major goals of the newly formed Signaling and Biotechnology (SBT) Program are to understand the
mechanisms underlying cancer pathogenesis and resistance to therapy and to use this knowledge to develop
new technologies leading to more effective strategies for improved detection and treatment of cancer. The SBT
program combines a range of disciplines (signaling biology and therapeutics, engineering, clinical medicine,
and physical sciences) with the goal of increasing basic knowledge and developing innovative technologies for
research, diagnosis, and treatment of cancer. We focus on difficult-to-treat cancers and those with high
incidence and mortality in the Wake Forest Baptist Comprehensive Cancer Center (WFBCCC) catchment area.

## Key facts

- **NIH application ID:** 9848540
- **Project number:** 5P30CA012197-45
- **Recipient organization:** WAKE FOREST UNIVERSITY HEALTH SCIENCES
- **Principal Investigator:** Hui-Kuan Lin
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $34,569
- **Award type:** 5
- **Project period:** — → —

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9848540

## Citation

> US National Institutes of Health, RePORTER application 9848540, Signaling and Biotechology Program (5P30CA012197-45). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/9848540. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*